Products billed under this code include Betamethasone Sodium Phosphate and Betamethasone Acetate, Celestone Soluspan.
Payment limit per 3 MG & 3 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Betamethasone Sodium Phosphate and Betamethasone Acetate | American Regent, Inc. | 00517-0791-01 | 5 | $35.875 |
| Betamethasone Sodium Phosphate and Betamethasone Acetate | American Regent, Inc. | 00517-0799-01 | 5 | $35.875 |
| Celestone Soluspan | American Regent, Inc. | 00517-0720-01 | 5 | $35.875 |
| Celestone Soluspan | Organon LLC | 78206-0118-01 | 5 | $35.875 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $7.175 | +$0.049 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted September 17, 2026 |
| 3Q26 | $7.126 | +$0.155 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted September 15, 2026 |
| 2Q26 | $6.971 | +$0.063 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted September 15, 2026 |
| 1Q26 | $6.908 | −$0.048 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted September 15, 2026 |
| 4Q25 | $6.956 | +$0.067 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted September 8, 2026 |
| 3Q25 | $6.889 | +$0.041 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted March 10, 2026 |
| 2Q25 | $6.848 | −$0.662 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted March 10, 2026 |
| 1Q25 | $7.51 | +$0.111 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted December 19, 2025 |
| 4Q24 | $7.399 | +$0.123 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted June 11, 2025 |
| 3Q24 | $7.276 | +$0.391 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted June 11, 2025 |
| 2Q24 | $6.885 | +$0.069 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted March 11, 2025 |
| 1Q24 | $6.816 | +$0.41 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted December 19, 2024 |
| 4Q23 | $6.406 | −$0.55 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted October 10, 2024 |
| 3Q23 | $6.956 | +$0.554 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted June 5, 2024 |
| 2Q23 | $6.402 | −$0.536 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted February 23, 2024 |
| 1Q23 | $6.938 | +$0.123 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted December 6, 2023 |
| 4Q22 | $6.815 | +$0.261 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted June 22, 2023 |
| 3Q22 | $6.554 | −$0.233 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted June 9, 2023 |
| 2Q22 | $6.787 | +$0.01 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted December 14, 2022 |
| 1Q22 | $6.777 | −$1.265 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted June 8, 2022 |
| 4Q21 | $8.042 | +$1.238 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted June 2, 2022 |
| 3Q21 | $6.804 | +$0.712 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted June 2, 2022 |
| 2Q21 | $6.092 | −$1.119 | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted March 1, 2022 |
| 1Q21 | $7.211 | – | 3 MG & 3 MG | Betamethasone acet&sod phosp | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
